ログイン
言語:

WEKO3

  • トップ
  • ランキング
To
lat lon distance
To

Field does not validate



インデックスリンク

インデックスツリー

メールアドレスを入力してください。

WEKO

One fine body…

WEKO

One fine body…

アイテム

  1. 紀要論文(本学刊行物)
  2. 岐阜歯科学会雑誌 Online edition: ISSN 2433-0191
  3. 51巻3号

Successful intravenous sedation using propofol and remifentanil in a patient with a gag refl ex: a case report

https://doi.org/10.15090/0002000375
https://doi.org/10.15090/0002000375
89fb494f-e116-45e7-9898-51f21cf22d8d
名前 / ファイル ライセンス アクション
gifushika513_119124_2025.pdf gifushika513_119124_2025.pdf (751 KB)
license.icon
Item type 紀要論文 / Departmental Bulletin Paper(1)
公開日 2025-03-31
タイトル
タイトル Successful intravenous sedation using propofol and remifentanil in a patient with a gag refl ex: a case report
言語 en
言語
言語 eng
キーワード
言語 en
主題Scheme Other
主題 Remifentanil
キーワード
言語 en
主題Scheme Other
主題 Gag refl ex
キーワード
言語 en
主題Scheme Other
主題 Intravenous sedation
キーワード
言語 en
主題Scheme Other
主題 Dental treatment
資源タイプ
資源タイプ識別子 http://purl.org/coar/resource_type/c_6501
資源タイプ departmental bulletin paper
アクセス権
アクセス権 open access
アクセス権URI http://purl.org/coar/access_right/c_abf2
著者 後藤, 隆志

× 後藤, 隆志

WEKO 1391
CiNii ID 9000342905247

ja 後藤, 隆志

en GOTO, TAKASHI

Search repository
櫻井, 学

× 櫻井, 学

WEKO 11258

ja 櫻井, 学

Search repository
書誌情報 ja : 岐阜歯科学会雑誌
en : The Journal of Gifu Dental Society

巻 51, 号 3, p. 119-124, ページ数 6, 発行日 2025-02
出版者
言語 ja
値 岐阜歯科学会
抄録
内容記述タイプ Other
内容記述 Intravenous sedation is a common approach for patients with gag reflex during dental procedures.However, deep sedation can lead to airway obstruction and coughing, hindering treatment. This case report describes the successful use of low-dose remifentanil for intravenous sedation in a 14-year-old intellectually disabled boy( height: 176 cm, weight: 65 kg) with dental caries, who was referred to our hospital for severe gag refl ex and dental phobia. Assessment revealed a gagging severity index of grade IV, and dental treatment was planned under intravenous sedation with preoperative fasting( normal meals: up to 6 h before sedation,clear liquids: up to 2 h before sedation). In Treatment 1, midazolam( 4 mg) and propofol( target controlled infusion[ TCI]: 2.0‒2.5 μg/mL, total dose: 600 mg) were used for sedation, with a treatment time and sedation time of 86 min and 105 min, respectively. In Treatment 2, remifentanil (0.05‒0.1 μg/kg/min, total dose: 0.3 mg) and propofol( TCI: 1.8‒2.0 μg/mL, total dose: 447 mg) were used, with a treatment and sedation time of 65 mins and 100 mins, respectively. Frequent coughing and body movement were observed during Treatment 1, resulting in persistent treatment interruptions. Conversely, Treatment 2 provided excellent intraoperative conditions with minimal coughing and improved vital sign stability, although mild respiratory depression was observed. Furthermore, Treatment 1 required airway management via chin lift maneuver due to oxygen desaturations. Regarding recovery time, Treatment 2 exhibited shorter times compared to Treatment 1 due to using a lower propofol dose.
Low-dose remifentanil may be useful for intravenous sedation in patients with gag refl ex. While this approach off ers promise, potential side eff ects, including respiratory depression and muscle rigidity (leadpipe henomenon), should be considered. Careful monitoring of vital signs and preparedness for possible complications (e.g., airway devices, pharmacological antagonists, neuromuscular blocking agents)are therefore necessary when considering intravenous sedation for dental procedures.
言語 en
ISSN
収録物識別子タイプ EISSN
収録物識別子 2433-0191
書誌レコードID
収録物識別子タイプ NCID
収録物識別子 AN00053070
著者版フラグ
出版タイプ VoR
出版タイプResource http://purl.org/coar/version/c_970fb48d4fbd8a85
関連サイト
関連タイプ isVersionOf
識別子タイプ NCID
関連識別子 AN00053070
見出し
大見出し Case Reports
言語 en
戻る
0
views
See details
Views

Versions

Ver.1 2025-03-27 04:36:24.545770
Show All versions

Share

Mendeley Twitter Facebook Print Addthis

Cite as

エクスポート

OAI-PMH
  • OAI-PMH JPCOAR 2.0
  • OAI-PMH JPCOAR 1.0
  • OAI-PMH DublinCore
  • OAI-PMH DDI
Other Formats
  • JSON
  • BIBTEX

Confirm


Powered by WEKO3


Powered by WEKO3